Results for the quarter ended 30.06.2025
Awaiting price reaction for this filing.
Sangam Health Care Products Ltd has filed its unaudited financial results for the quarter ended 30th June 2025 with BSE, following a Board Meeting. The specific figures for revenue, expenses, operating profit (EBITDA), and profit after tax (PAT) are not available in the provided headline. This is a standard quarterly compliance filing under SEBI listing obligations. Investors should refer to the detailed results PDF for actual numbers, segment performance, and any management commentary. Year-on-year and sequential comparisons would clarify the growth trajectory.
As a routine quarterly results filing, this announcement itself is procedural. The actual stock impact will depend on whether the reported numbers beat or miss market expectations, but no data is available to assess that here.